Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125077) titled 'Study on the Efficacy of Roseburia in the Treatment of Ulcerative Colitis' on May 21.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The 925th Hospital of Chinese People's Liberation Army Joint Logistic Support Force

Condition: Inflammatory Bowel Disease,Ulcerative Colitis

Recruitment Status: Not Recruiting

Phase: 0

Date of First Enrollment: 2026-06-01

Target Sample Size: Test group:9;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=320680

Published by HT Digital Content Services with permission from Health Daily Digest....